A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension
Open Access
- 7 December 2012
- journal article
- case report
- Published by Springer Nature in CEN Case Reports
- Vol. 2 (1) , 68-75
Abstract
Focal segmental glomerulosclerosis (FSGS) is associated with various clinicopathological conditions, including hypertension. We report here a case of secondary FSGS associated with malignant hypertension. A 33-year-old man with a 1-month history of visual impairment and headache visited the Department of Ophthalmology at our hospital and was found to have hypertensive retinopathy and severe hypertension (230/160 mmHg). He was referred to our department based on suspected renal dysfunction. His blood pressure on admission was 250/130 mmHg. Physical examination and laboratory tests revealed hypertensive cardiac dysfunction, focal brain edema, renal dysfunction (serum creatinine, Cr 7.07 mg/dl, blood urea nitrogen, BUN 49.9 mg/dl), massive proteinuria (10.7 g/day), and thrombotic microangiopathy. Funduscopy showed exudate, hemorrhage, and papilledema. The cause of secondary hypertension could not be identified. He was treated for primary malignant hypertension, but required hemodialysis 3 days after admission due to anuria. Treatment with antihypertensive agents resulted in the gradual recovery of renal function, although heavy proteinuria continued with nephrotic syndrome. Renal biopsy performed 1 month after admission showed features of malignant nephrosclerosis with secondary FSGS. Hemodialysis was discontinued following further improvement in renal function and the most recent laboratory tests showed proteinuria 1.8 g/day and persistent renal dysfunction (BUN 36.5 mg/dl, Cr 3.14 mg/dl). Malignant hypertension may cause various injuries, including glomerular endothelial and epithelial cell injuries in glomerular hypertension and hyperfiltration, increase of the renin–angiotensin–aldosterone system, and endothelial–epithelial interaction, resulting in the development of secondary FSGS and heavy proteinuria.Keywords
This publication has 39 references indexed in Scilit:
- Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic RatsAmerican Journal of Hypertension, 2012
- Macrophages in Renal DiseaseJournal of the American Society of Nephrology, 2011
- Glomerular Disturbances in Preeclampsia: Disruption Between Glomerular Endothelium and Podocyte SymbiosisHypertension in Pregnancy, 2010
- Dendritic cells and macrophages in kidney diseaseClinical and Experimental Nephrology, 2009
- Renal manifestations in toddlers with Takayasu’s arteritis and malignant hypertensionPediatric Nephrology, 2009
- Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patientsHypertension Research, 2009
- Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinasesBiochemical and Biophysical Research Communications, 2008
- Angiotensin II Type 1 and Type 2 Receptors Play Opposite Roles in Regulating the Barrier Function of Kidney Glomerular Capillary WallThe American Journal of Pathology, 2007
- Renovascular Hypertension: A Unique Cause of Unilateral Focal Segmental GlomerulosclerosisHypertension Research, 2006
- Renal biopsy findings in hypertensive patients with proteinuriaThe Lancet, 1992